therapeutic drug monitoring of immunosuppressants: an overview

Posted by Neoteryx on Jan 6, 2020 2:52:00 AM

When administering immunosuppressants, clinicians need to individualize a patient’s drug therapy. The goal is to attain an optimal balance between therapeutic efficacy and the probability of adverse effects. Patients present varying pharmacodynamics and pharmacokinetics, so achieving this goal can be challenging.

Read More

Topics: Alternative to Dried Blood Spot, Alternative to Venipuncture, Immunosuppressants

smarter, simpler immunosuppressant monitoring: the promise of capillary blood microsampling innovation

Posted by Neoteryx on Dec 17, 2019 4:04:00 AM

For many organ transplant patients, immunosuppressant monitoring is a fact of life. But that does not mean that it cannot be significantly improved. For proof, look no further than the remote blood sampling capabilities provided by Mitra® microsampling devices, driven by Volumetric Absorptive Microsampling (VAMS®) technology.

Read More

Topics: Immunosuppressants

blood microsampling brings quantification to anti-doping research

Posted by Neoteryx on Dec 13, 2019 4:45:00 AM

Capillary Blood Microsampling in Anti-doping Research

In the arena of athletic competition, curtailing the use of anabolic steroids is one of the most significant challenges. This category includes the performance-enhancing substances that athletes most commonly abuse in the interest of gaining an unfair advantage.

Read More

Topics: Remote Patient Monitoring

microsampling in pharmaceutical drug discovery and development: the patient-centric approach

Posted by Neoteryx on Dec 9, 2019 4:46:00 AM

Patient-centric healthcare has taken center-stage. With the increasing access to information, patients want to play a role in treatment methods and applications. Patient-centric sampling has an important part to play.

Read More

Topics: Clinical Trials, Alternative to Dried Blood Spot, Alternative to Venipuncture, Remote Patient Monitoring

smarter monitoring for PEth: new dimensions in alcohol testing

Posted by Neoteryx on Dec 5, 2019 1:45:00 AM

Many patients come to Dr. Bruno Journe, a specialist in addictology, for help with their problematic consumption of alcohol. Until recently, “there was no criterion to distinguish between a subjective and an objective relation to the misuse of alcohol,” says Dr. Journe. “Even a biological test such as MCG, ASAT, ALAT, GGT, or CDT lacks sensitivity and can lead to the wrong diagnosis.”

This is changing now thanks to advancing methods of measuring phosphatidylethanol, or PEth, a biomarker produced in cell membranes that correlates with recent alcohol use in a way that is highly specific. “PEth brings unique information that was never available before,” Dr. Journe says. “Denial is no longer possible.”

Read More

Topics: Remote Patient Monitoring

5 remote patient monitoring devices to watch in 2020

Posted by Neoteryx on Dec 3, 2019 12:03:00 AM

In 2020, the capabilities of remote patient monitoring technology will be more powerful, effective, and interesting than ever before.

According to IHS (Information Handling Services), more than four million patients will monitor their health conditions remotely by 2020. This is a 34% increase in remote patient monitoring (RPM), thanks to many innovation advancements since 2014.

Read More

Topics: Remote Patient Monitoring